
For decades, the United States led the charge in the pursuit of brain-computer interface technology, betting big on bold, high-risk breakthroughs that promised to revolutionise medicine and human-machine integration.
In the end, it is China crossing the finish line first.
Advertisement
After decades of this technology being stuck in clinical trials globally, this feat makes their Neural Electronic Opportunity (Neo) implant the first invasive device in the world to be available outside trials.
Advertisement
The development of BCI has been defined by a difficult trade-off: a non-invasive approach that sacrifices precision or an invasive approach that sacrifices safety.

Don't Miss:
-
Hong Kong’s IP hub ambitions require sustained investment, coordination: experts
-
Japan’s wartime past weighs on growing military role in Philippines
-
Chinese coffee brands need more than low prices to compete with global players: analysts
-
Taylor Swift sued for trademark infringement over Life of a Showgirl album title
-
Iran’s Islamic republic will ‘collapse internally’, says Netanyahu

France to try alleged Magnitsky Affair mastermind Dimitry Klyuev in absentia
Canada revokes dozens of crypto firms’ registrations
Questions swirl around US plans for record $15B Prince Group crypto seizure